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Abstract:  
The Ag85 family enzymes are responsible for the synthesis of cell wall components in mycobacterial species. Inhibitors to 
these enzymes are potential antimycobacterial agents. We have carried out the docking of phoshonate and trehalose analog 
inhibitors into the three dimensional structure of mycolyltransferase enzyme, Ag85C of M. tuberculosis using the GOLD 
software. The inhibitor binding positions and affinity were evaluated using both the scoring fitness functions- GoldScore 
and ChemScore. We observed that the inhibitor binding position identified using the GoldScore was marginally better than 
the ChemScore. A qualitative agreement between the reported experimental biological activities (IC50) and the GoldScore 
was observed. We identified that amino acid residues Arg541, Trp762 are important for inhibitor recognition via hydrogen 
bonding interactions. This information can be exploited to design Ag85C specific inhibitors. 
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Background: 
Tuberculosis is an infection caused by the bacterium 
Mycobacterium tuberculosis. It is a major disease infecting 
two billion people, or approximately one-third of the 
world’s population. These numbers are rising also in the 
developed countries due to the compromised immune 
systems, typically as a result of immunosuppressive drugs. 
This population is at particular risk of infection and active 
tuberculosis disease.  
 
In  M. tuberculosis, a major secreted protein complex, 
antigen 85, constitutes three proteins antigen 85A, 85B and 
85C  [1] that are responsible for the synthesis of cell 
envelope. These enzymes catalyze the transfer of mycolyl 
residue from one molecule of α, α’ trehalosemonomycolate 
(TMM) to another TMM leading to the formation of α, α’ 
trehalosedimycolate (TDM) [2] and are hence termed 
mycolyltransferases. These enzymes have the ability to 
bind the human fibronectin [3] through which the 
bacterium gets attached to host cells. Due to their 
immunodominant and secretory nature, the components of 
Ag85 complex represent promising protective antigen 
candidates. Also, the cell envelope of M. tuberculosis has 
been one of the targets of antimycobacterial agents. Drugs 
such as isoniazid, ethionamide, isoxyl, thiolactomycin, and 
triclosan and ethambutol, target the synthesis of mycolic 
acids in M. tuberculosis. In addition, pyrazinamide was 
shown to inhibit fatty acid synthase type I that in turn, 
provides precursors for fatty acid elongation to long-chain 
mycolic acids by fatty acid synthase II. [4] Mycolic acid 
biosynthesis is known to be essential for mycobacterium
 
growth, in particular trehalose mycolates aid in virulence of 
the organism and
 the structure of mycolates has been found 
to be important
  for initial replication and persistence in 
vivo.  [5]  A mutated M. tuberculosis strain lacking the 
functional Ag85C gene showed a 40% decrease in the 
amount of cell wall linked mycolic acids indicating its role 
in cell wall synthesis. [6] The importance of 
mycolyltransferases in pathogenesis and cell wall formation 
makes them an attractive target for drug design studies. A 
series of 6,6’-bis(sulfonamido), N,N’-dialkylamino and 
related derivatives of 6,6’-dideoxytrehalose were designed 
and synthesized to inhibit the Ag85 complex. [7]  
 
The three dimensional crystal structures of Ag85A (PDB 
ID: 1SFR) [8] Ag85B (PDB IDs: 1F0N, 1F0P) [9] and 
Ag85C (PDB IDs: 1DQZ, 1DQY, 1VA5) [10] were 
determined for both native and substrate bound forms. The 
protein structure corresponds to a α/β hydrolase fold and 
the catalytic triad responsible for the mycolyltransferase 
activity comprise the amino acid residues Ser624, Glu728 
and His760 (numbering according to the PDB_ID: 1DQZ, 
B chain). This active site is typical of a serine protease 
family. Structural comparison of mycolyltransferases 
revealed that their backbone superimposes with an overall 
RMSD (root mean square deviation) of 0.577 Å. The 
catalytic residues are highly superimposed in these 
structures indicating that the structure and function of these 
isozymes are highly similar. Minor deviations are observed 
in the loop region connecting strand 4 and helix 3, 
comprising the sequence motif, 85Q-S-N-G-Q-N90 in 
Ag85C. This region is away from the substrate binding site 
and therefore will not affect substrate/inhibitor binding to 
the enzyme. A putative picture of the catalytic mechanism 
of the mycolyl transfer reaction been proposed by Ronning 
et al., 2000. [10] In the first step, catalytic serine attacks the Bioinformation by Biomedical Informatics Publishing Group                   open access 
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carboxyl carbon of TMM molecule to give a 
mycolylenzyme intermediate and a free trehalose. In the 
next step, the 6’-OH group of the second TMM molecule 
attacks the carboxylate carbon of the acyl-enzyme 
intermediate to yield TDM. Both acylation and deacylation 
of the enzyme, proceed via a high-energy tetrahedral 
transition state. It is known that substituted tetrahedral 
phosphorus (V) species like phosphonates, 
phosphonamidates and phosphinates represent good 
tetrahedral transition state analogous of both amide and 
ester bond cleavage or formation. Incorporation of the 
phosphorus based transition state mimetics into the 
substrate or product analogs generally leads to useful 
enzyme inhibitors. Gobec et al., 2004 [11] synthesized a 
series of phosphonate inhibitors and reported the inhibition 
of Ag85C mycolyltransferase activity in the presence of 
inhibitors. Rose et al., 2002 [7] studied the 
antimycobacterial activity of trehalose analogs against M. 
tuberculosis H37Ra and clinical isolates of M. avium.  
  
Several groups have earlier carried out a comparative 
evaluation of the docking methods and scoring functions. 
[14, 15, 16] Results from Verdonk et al., 2003 [13] 
indicated that for “drug like” and “fragment like” ligands, 
the docking accuracies obtained from GoldScore and 
ChemScore are similar, while for larger ligands, GoldScore 
gave better results. Docking involves the identification of 
ligand conformation and orientation in the protein binding 
pockets. The scoring functions are helpful to predict the 
biological activity of the ligand. The aim of the present 
work is to study the docking of phosphonate and trehalose 
analog inhibitors into the active site of Ag85C using the 
GOLD software. [12, 13] In this work, we compared the 
scoring functions, GoldScore and ChemScore that are 
available in the Gold docking software. The three 
mycolyltransferases have highly similar structure, we have 
therefore chosen the three dimensional structure of Ag85C 
(PDB ID: 1DQZ) as a representative structure for docking 
studies. Also, the inhibition of Ag85C by the phosphonate 
inhibitors by Gobec et al., 2004 has been studied and the 
experimental IC50 values are reported. Since this enzyme 
functions as a serine protease, these docking studies will 
help characterize the inhibitor binding site. The information 
about the inhibitor binding site can be used to design 
Ag85C specific inhibitors that would not interfere with the 
other physiologically important ubiquitous serine proteases 
in humans.  
 
Methodology: 
Energy minimization of protein:   
The crystal structure coordinates of the Ag85C (PDB_ID: 
1DQZ) were obtained from the protein data bank 
(http://www.rcsb.org/) and the B chain was selected for 
docking studies. All hydrogen atoms were added to the 
protein, including those necessary to define the correct 
ionization and tautomeric states of amino acid residues 
such as Asp, Ser, Glu, Arg and His using Cache software 
(www.cachesoftware.com/cache). A two stage protocol was 
set up for the energy minimization of protein using 
Hyperchem7 (Hypercube Inc.), molecular modeling 
software. In the first stage, all hydrogen atoms in the 
protein were allowed to optimize. The hydrogen locations 
are not specified by the X-ray structure but these are 
necessary to improve the hydrogen bond geometries. In the 
second stage, all protein atoms were allowed to relax. 
Minimization in both stages was performed using 100 steps 
of steepest descent and 2000 steps of conjugate gradient 
algorithm. 
 
Binding site analysis:  
The binding site identification of mycolyltransferases, 
Ag85A, Ag85B and Ag85C was carried out using the 
Binding Site Analysis module available in Insight II 
(Acclerys, USA). The default parameters for grid size 1.00 
Å and site open size 7.00 Å were used in binding site 
calculation. 
 
Selection of docking molecules:  
A set of 17 phosphonate inhibitors is taken from the 
reported literature [11] for the docking studies. A list of 
these molecules is provided in Figure 1a and a schematic 
representation of the molecules with least IC50 values is 
provided in Figure 1b.  Similarly, a set of 9 trehalose 
analogs is taken from the reported literature [7] for docking 
studies. A list of these molecules is provided in Figure 5a 
and a schematic representation of the molecules with least 
MIC values are provided in Figure 5b.  We have adapted 
the numbering of these inhibitors as represented in the 
original papers. [7, 11] 
 
Molecular Modeling:  
The phosphonate and trehalose analog inhibitors were built 
using the Hyperchem7. The structures were energy 
minimized using the steepest descent algorithm with a 
convergence gradient value of 0.001 kcal/mol. Further, the 
geometry optimization was carried out for each compound 
using the MOPAC 6 package and the semi empirical AM1 
Hamiltonian. 
 
Docking:  
Docking was carried out using GOLD (Genetic 
optimization for Ligand Docking) software, that uses the 
Genetic algorithm (GA). This method allows a partial 
flexibility of protein and full flexibility of ligand. All water 
molecules and hetero atoms were removed from the protein 
to evaluate the two scoring functions in GOLD software. 
For each of the 25 independent GA runs, a maximum 
number of 100000 GA operations were performed on a set 
of five groups with a population size of 100 individuals. 
Operator weights for crossover, mutation, and migration 
were set to 95, 95, and 10, respectively. Default cutoff 
values of 2.5 Å (dH-X) for hydrogen bonds and 4.0 Å for 
van der Waals distance were employed. When the top three 
solutions attained RMSD values within 1.5 Å, GA docking Bioinformation by Biomedical Informatics Publishing Group                   open access 
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was terminated. The RMSD values for the docking 
calculations are based on the RMSD matrix of the ranked 
solutions. We observed that the best ranked solutions were 
always among the first 10 GA runs, and the conformation 
of molecules based on the best fitness score was further 
analyzed. All the 17 phosphonate and 9 trehalose analog 
inhibitors were analyzed using docking studies and the 
molecules with least IC50 and MIC values respectively in 
each group are described in detail in the results and 
discussion section. 
 
 
Figure 1: (a) A list of 17 phosphonate inhibitors docked into the active site of mycolyltransferase, Ag85C. The reported Ic50 
values of the corresponding molecules are also indicated. (b) A schematic representation of the phosphonate inhibitors with 
least Ic50 values 
  
The two scoring functions available in the GOLD software 
to measure the affinity of ligand for protein binding site 
are: 
 
GoldScore fitness function:  
GoldScore performs a force field based scoring function 
and is made up of four components: 1. Protein-ligand 
hydrogen bond energy (external H-bond); 2. Protein-ligand 
van der Waals energy (external vdw); 3. Ligand internal 
van der Waals energy (internal vdw); 4. Ligand 
intramolecular hydrogen bond energy (internal- H- bond). 
The external vdw score is multiplied by a factor of 1.375 
when the total fitness score is computed. This is an 
empirical correction to encourage protein-ligand 
hydrophobic contact. The fitness function has been 
optimized for the prediction of ligand binding positions.  
GoldScore = S(hb_ext) + S(vdw_ext) + S(hb_int) + 
S(vdw_int)  
 
Where S(hb_ext) is the protein-ligand hydrogen bond 
score, S(vdw_ext) is the protein-ligand van der Waals 
score, S(hb_int) is the score from intramolecular hydrogen 
bond in the ligand and S(vdw_int) is the score from 
intramolecular strain in the ligand. 
 
ChemScore fitness function:  
ChemScore is an empirical scoring function to estimate the 
free energy of ligand binding to protein. It uses simple Bioinformation by Biomedical Informatics Publishing Group                   open access 
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contact terms to estimate lipophilic and metal-ligand 
binding contributions, including hydrogen bonding 
interactions. It does not differentiate between different 
types of hydrogen bonds, depending on the nature and 
geometry of the interaction. It adds a clash penalty and 
internal torsion terms, which influence against close 
contacts in docking and poor internal conformations. 
Covalent and constraint scores may also be included.  
 
ChemScore estimates the total free energy change that 
occurs on ligand binding to protein as per the equation 
given below  
 
 ∆G binding = ∆G o+ ∆G hbond + ∆G metal + ∆G lipo + ∆G rot                                                 
….. (1)   
 
Each component of this equation is the product of a term 
dependent on the magnitude of a particular physical 
contribution to free energy (e.g. hydrogen bonding) and a 
scale factor determined by regression.  
 
ChemScore  = ∆G binding + Pclash +Cinternal Pinternal + (Ccovalent 
Pcovalent + Pconstraint) ….. (2) 
                      
Results and Discussion: 
Binding site analysis of mycolyltransferases, Ag85A, 
Ag85B and Ag85C identified that, their binding pockets are 
identical and the largest binding pocket overlaps with the 
trehalose binding position in the PDB ID: 1F0P (data not 
shown). This further increased our confidence that the 
structures of mycolyltransferases are highly similar and we 
have therefore taken Ag85C as the representative structure 
for docking studies. The docking of phosphonate and 
trehalose analog inhibitors into the active site of 
mycolyltransferase, Ag85C was carried out using the 
GOLD software and the docking evaluations were made on 
the basis of two fitness functions, GoldScore and 
ChemScore. For both the scoring functions, the docking 
conformation generated with best fitness has been analyzed 
using two different criteria. These are 1) ligand binding 
position, and 2) fitness function score comparison.  
 
Phosphonate inhibitors: 
Criteria-1: Ligand binding position. From the docking of 
molecule 3c into the active site of Ag85C, we observed 
that, the hydrogen bond acceptor atoms are 6, 7 and 8, and 
atom 8 is also a hydrogen bond donor, as indicated in 
Figure 1b.  
 
GoldScore fitness function: One hydrogen bond was 
observed when the molecule 3c was docked into the active 
site of Ag85C, see Figure 2a and Table 1a. The alkyl chain 
of inhibitor entered into hydrophobic region of the protein 
comprising amino acid residues indicated in Table 2a. The 
best RMSD was found to be 0.28 Å. 
 
ChemScore fitness function: Two hydrogen bonds were 
observed when the molecule 3c was docked into active site 
of Ag85C, see Figure 3a and Table 1a. The alkyl chain of 
inhibitor entered into hydrophobic region of protein 
comprising amino acid residues indicated in Table 2a. The 
best RMSD was found to be 0.62 Å. 
 
Molecule Goldscore  ChemScore 
Mol 
Name 
No. of H 
bonds 
Protein 
residue atom 
Ligand 
atom 
H bond 
distance 
Å 
No. of 
H 
bonds 
Protein 
Residue atom 
Ligand 
atom 
H bond 
distance 
Å 
 
3c 
 
1 
 
Arg-541 
(NH) 
 
6(O) 
 
2.78 
 
2 
Arg-541 
(NH) 
Ser-624 
(OG) 
    6(O) 
 
8(O) 
   3.04 
 
2.94 
      4a 
 
       1  Arg-541 
(NH) 
14(O)  2.71       1  His -760 
(C=O) 
2(O) 3.08 
 
5e 
 
 
2 
Arg-541 
(NH) 
Trp-762 
(NE2) 
6(O) 
 
11(O) 
2.81 
 
3.12 
 
     1 
 
Ser-624 
(OG) 
 
12(O) 
 
2.65 
 
 
6b 
 
 
3 
    Arg-541 
(NH) 
Trp-762 
(NE1) 
Ser-624 
(OG) 
5(O) 
 
4(O) 
 
13(O) 
2.64 
 
3.11 
 
2.93 
 
 
1 
 
 
Ser-624 
(OG) 
 
 
5(O) 
 
 
2.41 
Table 1a: List of hydrogen bonding interactions between the phosphonate inhibitors and mycolyltransferase, Ag85C 
 
From the docking of molecule 4a into the active site of 
Ag85C, we observed that the hydrogen bond acceptor 
atoms are 2, 3, 6 and 14 as indicated in Figure 1b. 
GoldScore fitness function: One hydrogen bond was 
observed when the molecule 4a was docked into the active 
site of Ag85C, see Figure 2b and Table 1a. The alkyl chain Bioinformation by Biomedical Informatics Publishing Group                   open access 
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of inhibitor entered into hydrophobic region of protein 
comprising amino acid residues indicated in Table 2a. The 
best RMSD was found to be 0.90 Å.  
 
ChemScore fitness function: One hydrogen bond was 
observed when the molecule 4a was docked into active site 
of Ag85C, see Figure 3b and Table 1a. The alkyl chain of 
inhibitor entered into hydrophobic region of protein 
comprising amino acid residues, as shown in Table 2a. The 
best RMSD was found to be 0.80 Å.  
 
From the docking of molecule 5e into the active site of 
Ag85C, we observed that, the hydrogen bond acceptor 
atoms are 2, 3, 4, 6, 11, and 12 as indicated in Figure 1b. 
 
GoldScore fitness function: Two hydrogen bonds were 
observed when the molecule 5e was docked into active site 
of Ag85C, see Figure 2c and Table 1a. The alkyl chain of 
inhibitor entered into hydrophobic region of protein 
comprising amino acid residues, as indicated in Table 2a. 
The best RMSD was found 0.61 Å.  
ChemScore fitness function: One hydrogen bonding 
interaction was observed when the molecule 5e was docked 
into the active site of Ag85C, see Figure 3c and Table 1a. 
The inhibitor alkyl chain entered into hydrophobic region 
of protein comprising amino acid residues as indicated in 
Table 2a. The best RMSD was found to be 0.82 Å. 
 
From the docking of molecule 6b into the active site of 
Ag85C, we observed that, the hydrogen bond acceptor 
atoms are 1, 4, 5, 13, 14 and 15, and the atom 14 is also a 
hydrogen bond donor, as indicated in Figure 1b. 
 
GoldScore fitness function: Three hydrogen bonds were 
observed when molecule 6b was docked into the active site 
of Ag85C, see Figure 2d and Table 1a. The alkyl chain of 
ligand entered into hydrophobic region of protein 
comprising residues as indicated in Table 2a. The best 
RMSD was found to be 1.04 Å. 
 
 
Figure 2: GoldScore based interactions of molecules (a) 3c (b) 4a (c) 5e and (d) 6b, docked into the active site of 
mycolyltransferase, Ag85C 
ChemScore fitness function: One hydrogen bonding 
interaction was observed when molecule 6b was docked 
into the active site of Ag85C with a distance of 2.41 Å, see 
Figure 3d and Table 1a. The alkyl chain entered into 
hydrophobic region of protein comprising amino acid 
residues as indicated in Table 2a. The best RMSD was 
found to be 1.01 Å. Bioinformation by Biomedical Informatics Publishing Group                   open access 
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Figure 3: ChemScore based interactions of molecules (a) 3c (b) 4a (c) 5e and (d) 6b, docked into the active site of 
mycolyltransferase, Ag85C 
 
Criteria-2: Fitness function score comparison. The 
phosphonate inhibitors were docked into the active site of 
Ag85C and evaluated based on both the fitness scoring 
functions- GoldScore and ChemScore available in the 
GOLD software. We observed that the GoldScore 
correlated well with the reported IC50 values as shown in 
Figure 4a. There are no compounds with high GoldScore 
and low activity (high IC50 values). The exceptions are 
molecules 3b and 3c that bind the Ag85C with a GoldScore 
of 50.30 and 51.18, while the IC50 values are 3.5 μM and 
1.06  μM, respectively. We hypothesize that the low 
GoldScore for these molecules is due to the presence of OH 
substitution alone on the phosphate head group. When the 
docked molecules were evaluated based on the ChemScore, 
there is no such correlation with the IC50 values, see 
Figure 4b. These results indicate that the GoldScore is a 
better parameter to assess the binding of phosphonate 
inhibitors to Ag85C and there is an overall 70-80 % 
correlation between the GoldScore and IC50 values. 
 
Trehalose analogs: 
Ligand binding position: From the docking of molecule 11b 
into the active site of Ag85C, we observed that, the 
hydrogen bond acceptor atoms are 7-12, 19-23, 25, 26, 54 
and 55. The atoms 8-10, 12, 19-21 23 are also hydrogen 
bond donors, as indicated in Figure 5b. 
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Figure 4: (a) GoldScore based docking of phosphonate inhibitors into the mycolyltransferase, Ag85C (b) ChemScore 
based docking of phosphonate inhibitors into the mycolyltransferase, Ag85C  
 
 
Figure 5: (a) A list of 9 trehalose analog inhibitors docked into the active site of mycolyltransferase, Ag85C. The 
reported MIC values of the corresponding molecules are also indicated (b) A schematic representation of the trehalose 
analog inhibitors with least MIC values  Bioinformation by Biomedical Informatics Publishing Group                   open access 
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GoldScore fitness function: Seven hydrogen bonds were 
observed when the molecule 11b was docked into the 
active site of Ag85C, see Figure 6a and Table 1b. The alkyl 
chain of the inhibitor entered into the hydrophobic region 
of the protein comprising amino acid residues indicated in 
Table 2b. The best RMSD was found to be 2.16 Å. 
 
  GoldScore ChemScore 
Mol 
Name 
No Of 
H 
bonds 
Protein 
residue atom 
Ligand 
atom 
H Bond 
distance 
Å 
No of 
H 
bonds 
Protein 
residue atom 
Ligand 
atom 
H bond 
distance 
Å 
Arg-541 
(N) 
25 (O)  2.51   Arg-541  
(O) 
25 (O)  3.13 
Trp-762 
(NE1) 
26 (O)  3.63  
Trp-762 
(NE1) 
26 (O)  2.80  
Gln-543 
(NE2) 
9 (O)  3.04  
Gln-543 
(NE2) 
11 (O)  2.95  
Gln-543 
(NE2) 
10 (O)  2.52  
Asn-552 
(OD1) 
23 (N)  3.28  
 
 
 
 
 
 
11b 
 
 
   
 
 
 
   7 
 
 
 
  Asn-552 
(O) 
54 (O)  3.21  
 
 
 
 
 
 
4 
Asn-552 
(O) 
19 (O)  3.07  
Arg-541 
 (N) 
22 (O)  3.85   Arg-541 
(N) 
 
20 (O) 
 
3.19 
 
Ser-624 
(OG) 
19 (O)  3.21  
Ser-624 
(O) 
12 (N)  3.34 
His-760 
(O) 
20 (O)  3.02  
 
 
 
 
 15a 
 
 
 
 
   4 
Trp-762 
(NE1) 
23 (N)  3.43  
 
 
 
 
    3 
His-760 
(O) 
23 (N)  3.03 
Ser-624 
(OG) 
20 (O)  3.30   His-760 
(NE2) 
19 (O)  3.30 
His-760 
(O) 
10 (O)  3.19  
 
 
 18b 
 
 
 
 
 
   3 
Trp-762 
(NE1) 
23 (N)  2.94  
 
 
 
    2 
His-760 
(NE2) 
 
20 (O)  2.76 
Table 1b: List of hydrogen bonding interactions between the trehalose analog inhibitors and mycolyltransferase, Ag85C   
      
ChemScore fitness function: Four hydrogen bonds were 
observed when the molecule 11b was docked into active 
site of Ag85C, see Figure 7a and Table 1b. The alkyl 
chain of the inhibitor entered into hydrophobic region of 
protein comprising amino acid residues, as indicated in 
Table 2b. The best RMSD was found to be 2.64 Å.  
 
Phosphonate 
    inhibitor 
                                    GoldScore                            ChemScore 
          3c  Gly539, Leu540, Ala665, Phe576, Phe650, Leu727, Leu623
Ser624, and Met625 
Gly539, Leu540, Ala665, Phe576, Phe650, Leu727, 
Ile662, Ser624, Met625 and Trp658 
          4a  Leu540,  Met625,  Phe576,  Leu727,  Phe650,  Leu661, 
Ile662, Ala665, Trp658, and Ser624 
Trp762, Ala724, and His760 
          5e  Leu540,  Leu727, Phe650, Leu661, Ile662, Trp658, and 
Ser624 
Leu540, Asp538, Gly539, Leu623, Ser624 
       6b  Leu727, Phe650, Leu661, Ile662, Trp658, and His760  Gly548, Gly539, Leu623, Asp538 and Trp762 
Table 2a: List of amino acid residues contributing to the hydrophobic pocket in docking of phosphonate inhibitors into 
mycolyltransferase, Ag85C 
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Table 2b: List of amino acid residues contributing to the hydrophobic pockets in docking of trehalose analog inhibitors into 
mycolyltransferase, Ag85C 
 
From the docking of molecule 15a into the active site of 
Ag85C, we observed that, the hydrogen bond acceptor 
atoms are 7-12, 19-23. The hydrogen bond donor atoms are 
8-10, 12, 19-21 and 23, as indicated in Figure 5b. 
  
GoldScore fitness function: Four hydrogen bonds were 
observed when the molecule 15a was docked into the active 
site of Ag85C, see Figure 6b and Table 1b. The alkyl chain 
of the inhibitor entered into the hydrophobic region of the 
protein comprising amino acid residues as indicated in 
Table 2b. The best RMSD was found to be 0.78 Å. 
 
ChemScore fitness function: Three hydrogen bonds were 
observed when the molecule 15a was docked into active 
site of Ag85C, see Figure 7b and Table 1b. The alkyl chain 
of inhibitor entered into hydrophobic region of protein 
comprising amino acid residues, as indicated in Table 2b. 
The best RMSD was found to be 1.60 Å.  
 
From the docking of molecule 18b into the active site of 
Ag85C, we observed that, the hydrogen bond acceptor 
atoms are 7-12, 19-23, the hydrogen bond donor atoms are 
8-10, 12, 19-21, 23, as indicated in Figure 5b.  
 
GoldScore fitness function: Three hydrogen bonds were 
observed when the molecule 18b was docked into the 
active site of Ag85C, see Figure 6c and Table 1b. The alkyl 
chain of the inhibitor entered into the hydrophobic region 
of the protein comprising amino acid residues, as indicated 
in Table 2b. The best RMSD was found to be 2.34 Å. 
 
ChemScore fitness function: Two hydrogen bonds were 
observed when the molecule 18b was docked into active 
site of Ag85C, see Figure 7c and Table 1b. The alkyl chain 
of inhibitor entered into hydrophobic region of protein 
comprising amino acid residues, as indicated in Table 2b. 
The best RMSD was found to be 2.28 Å. 
For the trehalose analog inhibitors, Rose et al., 2002 [7] 
have reported the MIC values in order to estimate their 
activity as antimycobacterial agents, therefore, we have not 
correlated them with the GoldScore and ChemScore.  
 
In the crystal structure of Ag85B complexed with trehalose 
substrate (PDB ID: 1F0P), it has been shown that Ser124 
(equivalent of Ser624 in Ag85C, B chain) forms a 
hydrogen bonding interaction with atom O6 of trehalose. 
[9]  From our docking studies, we have shown that this 
serine forms a hydrogen bonding interactions with 
phosphonate and trehalose analog inhibitors (see Tables 1a 
and 1b). Further, we also identified additional amino acid 
residues, Arg541 and Trp762 important for inhibitor 
recognition mediated via non-bonding interactions. 
Sequence analysis identified that Arg541, Ser624 and 
Trp762 are highly conserved in mycolyltransferases [17] of 
M. tuberculosis. Current docking studies using the 
GoldScore fitness function reported a hydrophobic tunnel 
to accommodate the hydrocarbon alkyl chain of 
phosphonate and R1 alkyl chain of trehalose analog 
inhibitors. This hydrophobic tunnel comprises the residues 
Leu540, Phe576, Phe650, Trp658, Leu661, Ile662, Leu623, 
Met625, Ala665 and Leu727. In the reported crystal 
structures of Ag85B and Ag85C [9, 10], the authors have 
described a hydrophobic tunnel comprising these residues 
to accommodate α- alkyl chain of mycolic acids. It was 
also proposed that β- alkyl chain of mycolic acids would fit 
the trough on the surface of the protein. Docking of 
trehalose analog inhibitors identified the R2 alkyl chain to 
bind the region comprising amino acid residues Tyr510, 
Gln525, Ala542, Gln543, Asp545, Gly548, Asp550, Ile551, 
Asn552, Pro554 that are located on the surface of the 
protein. These results indicate that the predicted 
nonbonding interactions and hydrophobic region to 
accommodate the alkyl chains are similar to the 
experimental data obtained from crystal structures.
Trehalose 
inhibitors 
GoldScore  ChemScore 
R1             R2               R1             R2     
       
    
       11b 
Ala665, Leu661, 
Ile662, Leu540, 
Gly539, Met625, 
Leu727, Phe650, 
Leu623 
Pro763, Thr553, 
Ala555, Pro554, 
Ile551, Asp550 
Ala542, Gle539, 
Leu540, Leu727, 
Leu727 Trp765 
Tyr546,Gln525,T
yr510, Asp550, 
Ile551 
   
       15a 
Leu540, Ala665, 
Ile662, Leu661, 
Trp658, Leu730, 
Phe650, Leu727 
Ala542, Gln543, 
Gly548, Asn552 
Leu540, Phe576, 
Ala665, Ile662, 
Leu661, Trp658, 
Phe650, Leu730 
Gly548, Asn552, 
Pro763, Gly719, 
Trp762 
 
       18b 
Leu540, Ala665, 
Ile662, Leu661, 
Trp658, Leu730, 
Phe650, Leu727 
Ala542, Gln543, 
Gly548, 
Asn547, Ile551, 
Asn552 
Ala665, Ile662, 
Leu661,Trp658, 
Leu730, Phe650, 
Leu727 
Ala542,Gln543, 
Asp545, Ile551, 
Gly548 Bioinformation by Biomedical Informatics Publishing Group                   open access 
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Figure 6: GoldScore based interactions of molecules (a) 11b (b) 15a and (c) 18b docked into the active site of 
mycolyltransferase, Ag85C 
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Figure 7: ChemScore based interactions of molecules (a) 11b (b) 15a and (c) 18b docked into the active site of 
mycolyltransferase, Ag85C 
 
Conclusion:  
A detailed docking analysis of phosphonate and trehalose 
analog inhibitors into the active site of Ag85C has been 
studied in the present work, to identify the inhibitor binding 
position and affinity to Ag85C using the Gold software. We 
report that the GoldScore fitness function is marginally 
better than the ChemScore fitness function, to understand 
the binding conformation. Also, GoldScore provides a 
qualitative agreement with the reported IC50 values of 
phosphonate inhibitors.  
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